GALECTIN THERAPEUTICS INC

GALT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 9 employees
341
SEC Filings
$2.79
Close 2026-05-26
9
Employees

Business Summary

PART I Overview We are a clinical stage biopharmaceutical company engaged in drug research and development to create new therapies for fibrotic disease, cancer and selected other diseases. Our drug candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. We use naturally occurring, readily-available plant products as starting material in manufacturing processes to create proprietary, patented complex carbohydrates with speci...

Latest Stock Quote

GALT 2026-05-26 $2.79 O:$2.57 H:$3.11 L:$2.525 Vol:1.0M VWAP:$2.9071
origin leaf: 6be6cbf07896fb201f9c7141320c4c2dec35a41d7bd22e70264a574a3394bbf5

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001140361-26-012155EDGAR63K words
2025-03-312024-12-310001140361-25-011169EDGAR—
2024-03-292023-12-310001140361-24-016452EDGAR—
2023-03-302022-12-310001140361-23-014658EDGAR—
2022-03-312021-12-310001140361-22-012058EDGAR—
2021-03-312020-12-310001193125-21-101402EDGAR—
2020-03-162019-12-310001193125-20-073907EDGAR—
2019-03-062018-12-310001193125-19-064705EDGAR—
2018-03-292017-12-310001193125-18-100592EDGAR—
2017-03-282016-12-310001193125-17-098753EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001140361-25-042116EDGAR24K words
2025-08-142025-06-300001140361-25-031039EDGAR—
2025-05-152025-03-310001140361-25-019149EDGAR—
2024-11-142024-09-300001140361-24-046726EDGAR—
2024-08-132024-06-300001140361-24-036937EDGAR—
2024-05-152024-03-310001140361-24-026105EDGAR—
2023-11-132023-09-300001140361-23-052729EDGAR—
2023-08-142023-06-300001140361-23-039411EDGAR—
2023-05-152023-03-310001140361-23-024499EDGAR—
2022-11-142022-09-300001140361-22-041167EDGAR—
2022-08-152022-06-300001140361-22-029555EDGAR—
2022-05-162022-03-310001140361-22-019248EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001140361-26-012158EDGAR2K words
2026-03-170001140361-26-009735EDGAR—
2026-01-210001140361-26-001866EDGAR—
2026-01-120001140361-26-000994EDGAR—
2025-12-190001140361-25-046115EDGAR—
2025-12-080001140361-25-044711EDGAR—
2025-12-030001140361-25-044148EDGAR—
2025-11-140001140361-25-042118EDGAR—
2025-11-100001140361-25-041275EDGAR—
2025-09-080001140361-25-034242EDGAR—

341 total filings indexed. 309 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001133416
TickerGALT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
Websitehttps://www.galectintherapeutics.com
Listed2002-09-04

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: cca5789180fbd6004e1060609ca984125e7345164a2b1e4e3a457410728333e5
parent: 19b5f28df222da83a9efb4308946a65c239b466c7c0311cb614703149fd5e519
content hash: af4ceb44a51b622a9d8a641ee835a53fe231dbafe52d1b21288089e51df69455
signed: 2026-06-02T19:01:12.634Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf